HIGHLIGHTS
- who: Zahra Jabbarpour from the Metabolism Molecularu2011Cellular Sciences Institute, Tehran University Tehran, Iran have published the research: Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells, in the Journal: (JOURNAL)
- what: This study aimed to establish a xeno-free/GMP-compliant protocol for FPMSCs manufacturing. Regarding the possible importance of MSCs in support of islet regeneration and considering the unique potential of FPMSCs in the treatment of diabetes, the authors aimed to optimize the FPMSCs` expansion under xenofree/GMP-compliant conditions. The authors evaluate the tumorigenicity potential of in_vitro . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.